10:00 Thu 05 Dec 2019
Alliance Pharma PLC - Director's Dealing
("Alliance" or the "Group")
Director's Dealing
Following this exercise, on
The 1,500,000 Ordinary Shares will be admitted to trading pursuant to an existing block listing, and will rank pari passu with the existing Ordinary Shares in issue.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||||||
a) |
|
|
|||||||
2 |
Reason for the notification |
||||||||
a) |
Position/status |
Chief Financial Officer |
|||||||
b) |
Initial notification /Amendment |
Initial Notification |
|||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||
a) |
|
|
|||||||
b) |
Legal Entity Identifier |
213800RYIWZA4Q5WPZ13 |
|||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of
GB0031030819 |
|||||||
b) |
Nature of the transaction |
a) Exercise of options b) Sale of Ordinary Shares |
|||||||
c) |
Currency |
GBP |
|||||||
d) |
Price(s) and volume(s) |
|
|||||||
|
|
||||||||
e) |
Aggregated information - Aggregated volume - Price - Aggregated total |
a) 1,500,000 options over Ordinary Shares, weighted average exercise price of b) 1,371,616 Ordinary Shares, sold at a price of
|
|||||||
f) |
Date of the transaction |
|
|||||||
g) |
Place of the transaction |
|
For further information:
Peter Butterfield, Chief Executive Officer
Andrew Franklin, Chief Financial Officer
Buchanan + 44 (0)20 7466 5000
Mark Court / Sophie Wills / Hannah Ratcliff
Numis Securities Limited + 44 (0)20 7260 1000
Nominated Adviser: Freddie Barnfield, Huw Jeremy
Corporate Broking: James Black
This information is provided by RNS, the news service of the
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE